Characteristics | Brazil nut (n = 35) | Placebo (n = 42) |
---|---|---|
Age – years | 59.6 ± 10.8 | 60.4 ± 9.9 |
Elderly – n (%)* | 19 (54.3 %) | 22 (52.4 %) |
Male – n (%) | 20 (57.1 %) | 23 (54.8 %) |
Diabetes – n (%) | 17 (48.6 %) | 15 (35.7 %) |
BMI– kg/m2 | 29.9 ± 6.5 | 29.3 ± 4.8 |
Overweight / obesity – n. (%) | 27 (77.1 %) | 35 (83.3 %) |
Plasma selenium - μg/L | 88.7 ± 15.3 | 86.6 ± 17.2 |
Physical activity – n (%)†| 13 (37.1 %) | 14 (33.3 %) |
MET (kcal/day) | 23.8 ± 46.1 | 27.1 ± 53.8 |
Drug therapy – n (%) |  |  |
Lipid-lowering drugs | Â | Â |
 Statins | 31 (88.6) | 35 (83.3) |
 Ezetimibe | 18 (51.4) | 15 (35.7) |
 Fibrate | 15 (42.8) | 14 (33.3) |
Antihypertensive drugs | Â | Â |
 Diuretics | 25 (71.4) | 26 (61.9) |
 ACE Inhibitors | 16 (45.7) | 22 (52.4) |
 Calcium channel blockers | 14 (40.0) | 15 (35.7) |
 Sympatholytic | 31 (88.6) | 35 (83.3) |
 Vasodilators | 16 (45.7) | 20 (47.6) |
 ARB | 13 (37.1) | 14 (33.3) |